Table 5.
Variations of the laboratory analyses and vital signs between the screening visit and the final visit (ISOFEN2)
| Screening visit | Final visit | |
|---|---|---|
| Creatinine (mg/dL) | 0.98±0.10 | 0.96±0.12 |
| Urea (mg/dL) | 34±7.05 | 34±8.73 |
| ALT (U/L) | 24±10.71 | 23±12.04 |
| ALP (U/L) | 67±22.52 | 64±25.05 |
| GGT (U/L) | 20±16.23 | 22±18.04 |
| WBC (103/μL) | 6.26±1.29 | 6.64±1.41 |
| RBC (106/μL) | 5.11±0.43 | 5.12±0.41 |
| Platelet (103/μL) | 208±50.57 | 211±53.20 |
| Systolic blood pressure (mmHg) | 111±9.11 | 108±9.04 |
| Diastolic blood pressure (mmHg) | 66±4.09 | 64±5.84 |
| Heart rate (bpm) | 67±8.98 | 69±8.78 |
Note: Values are expressed as mean ± standard deviation.
Abbreviations: ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutamyl transpeptidase; WBC, white blood cells; RBC, red blood cells; n, number.